Fragment-Based Discovery of Novel Non-Hydroxamate LpxC Inhibitors with Antibacterial Activity.


Journal

Journal of medicinal chemistry
ISSN: 1520-4804
Titre abrégé: J Med Chem
Pays: United States
ID NLM: 9716531

Informations de publication

Date de publication:
10 12 2020
Historique:
pubmed: 20 11 2020
medline: 4 2 2021
entrez: 19 11 2020
Statut: ppublish

Résumé

UDP-3-

Identifiants

pubmed: 33210531
doi: 10.1021/acs.jmedchem.0c01215
doi:

Substances chimiques

Anilides 0
Anti-Bacterial Agents 0
Bacterial Proteins 0
Chelating Agents 0
Enzyme Inhibitors 0
Imidazoles 0
Piperidines 0
Amidohydrolases EC 3.5.-
UDP-3-O-acyl-N-acetylglucosamine deacetylase EC 3.5.1.-
Zinc J41CSQ7QDS

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

14805-14820

Auteurs

Yousuke Yamada (Y)

Taisho Pharmaceutical Co., Ltd., Saitama 331-9530, Japan.

Hajime Takashima (H)

Taisho Pharmaceutical Co., Ltd., Saitama 331-9530, Japan.

David Lee Walmsley (DL)

Vernalis (R&D) Ltd., Granta Park, Cambridge CB21 6GB, U.K.

Fumihito Ushiyama (F)

Taisho Pharmaceutical Co., Ltd., Saitama 331-9530, Japan.

Yohei Matsuda (Y)

Taisho Pharmaceutical Co., Ltd., Saitama 331-9530, Japan.

Harumi Kanazawa (H)

Taisho Pharmaceutical Co., Ltd., Saitama 331-9530, Japan.

Toru Yamaguchi-Sasaki (T)

Taisho Pharmaceutical Co., Ltd., Saitama 331-9530, Japan.

Nozomi Tanaka-Yamamoto (N)

Taisho Pharmaceutical Co., Ltd., Saitama 331-9530, Japan.

Junya Yamagishi (J)

Taisho Pharmaceutical Co., Ltd., Saitama 331-9530, Japan.

Risa Kurimoto-Tsuruta (R)

Taisho Pharmaceutical Co., Ltd., Saitama 331-9530, Japan.

Yuya Ogata (Y)

Taisho Pharmaceutical Co., Ltd., Saitama 331-9530, Japan.

Norikazu Ohtake (N)

Taisho Pharmaceutical Co., Ltd., Saitama 331-9530, Japan.

Hayley Angove (H)

Vernalis (R&D) Ltd., Granta Park, Cambridge CB21 6GB, U.K.

Lisa Baker (L)

Vernalis (R&D) Ltd., Granta Park, Cambridge CB21 6GB, U.K.

Richard Harris (R)

Vernalis (R&D) Ltd., Granta Park, Cambridge CB21 6GB, U.K.

Alba Macias (A)

Vernalis (R&D) Ltd., Granta Park, Cambridge CB21 6GB, U.K.

Alan Robertson (A)

Vernalis (R&D) Ltd., Granta Park, Cambridge CB21 6GB, U.K.

Allan Surgenor (A)

Vernalis (R&D) Ltd., Granta Park, Cambridge CB21 6GB, U.K.

Hayato Watanabe (H)

Taisho Pharmaceutical Co., Ltd., Saitama 331-9530, Japan.

Koichiro Nakano (K)

Taisho Pharmaceutical Co., Ltd., Saitama 331-9530, Japan.

Masashi Mima (M)

Taisho Pharmaceutical Co., Ltd., Saitama 331-9530, Japan.

Kunihiko Iwamoto (K)

Taisho Pharmaceutical Co., Ltd., Saitama 331-9530, Japan.

Atsushi Okada (A)

Taisho Pharmaceutical Co., Ltd., Saitama 331-9530, Japan.

Iichiro Takata (I)

Taisho Pharmaceutical Co., Ltd., Saitama 331-9530, Japan.

Kosuke Hitaka (K)

Taisho Pharmaceutical Co., Ltd., Saitama 331-9530, Japan.

Akihiro Tanaka (A)

Taisho Pharmaceutical Co., Ltd., Saitama 331-9530, Japan.

Kiyoko Fujita (K)

Taisho Pharmaceutical Co., Ltd., Saitama 331-9530, Japan.

Hiroyuki Sugiyama (H)

Taisho Pharmaceutical Co., Ltd., Saitama 331-9530, Japan.

Roderick E Hubbard (RE)

Vernalis (R&D) Ltd., Granta Park, Cambridge CB21 6GB, U.K.

Articles similaires

Vancomycin-associated DRESS demonstrates delay in AST abnormalities.

Ahmed Hussein, Kateri L Schoettinger, Jourdan Hydol-Smith et al.
1.00
Humans Drug Hypersensitivity Syndrome Vancomycin Female Male
Photosynthesis Ribulose-Bisphosphate Carboxylase Carbon Dioxide Molecular Dynamics Simulation Cyanobacteria
Humans Arthroplasty, Replacement, Elbow Prosthesis-Related Infections Debridement Anti-Bacterial Agents
Psoriasis Humans Magnesium Zinc Trace Elements

Classifications MeSH